Literature DB >> 19412702

The antimicrobial peptide HBD-2 and the Toll-like receptors-2 and -4 are induced in synovial membranes in case of septic arthritis.

D Varoga1, E Klostermeier, F Paulsen, C Wruck, S Lippross, L O Brandenburg, M Tohidnezhad, A Seekamp, B Tillmann, T Pufe.   

Abstract

Septic arthritis is frequently observed especially in immune-compromised or chronically diseased patients and leads to functional impairment due to tissue destruction. Recently, production of antimicrobial peptides (AMP) was observed in articular cartilage after exposure to bacteria. This report examines the role of synoviocyte-derived AMPs in innate defense mechanisms of articular joints. Samples of healthy, low-grade synovialitis and septic synovial membranes were assessed for the expression of human beta-defensin-2 (HBD-2) and Toll-like receptor-2 and -4 (TLR) by immunohistochemistry and enzyme-linked immunosorbent assay (ELISA). A stable synoviocyte line (K4IM) was used for in vitro experiments and assayed for endogenous HBD-2 and TLR production after exposure to inflammatory cytokines or bacterial supernatants by reverse transcription polymerase chain reaction (RT-PCR), real-time RT-PCR, Western blot, ELISA, and dual luciferase assay. Healthy human synovial membranes and cultured synoviocytes are able to produce HBD-2 and TLR-1-5 at basal expression levels. Samples of bacteria-colonized synovial membranes produce higher levels of HBD-2 when compared with samples of healthy tissues. K4IM synoviocytes exposed to Staphylococcus aureus, Pseudomonas aeruginosa, or proinflammatory cytokines demonstrated a clear HBD-2 transcription and protein induction. TLR-2 and -4 are known to have a critical role in the recognition of gram-positive and gram-negative bacteria in epithelia and are induced in mesenchymal synoviocytes after bacterial exposure on transcription and on protein level. This report demonstrates an unappreciated role of synovial membranes: samples of septic synovial membranes and cultured synoviocytes exposed to bacteria produce increased amounts of the AMP HBD-2 and the bacteria recognition receptors TLR-2 and -4. The induction of anti-inflammatory pathways in infected synoviocytes suggests involvement in intra-articular defense mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19412702     DOI: 10.1007/s00428-009-0780-4

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  42 in total

1.  Expression of natural peptide antibiotics in human articular cartilage and synovial membrane.

Authors:  F Paulsen; T Pufe; W Petersen; B Tillmann
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

2.  A peptide antibiotic from human skin.

Authors:  J Harder; J Bartels; E Christophers; J M Schröder
Journal:  Nature       Date:  1997-06-26       Impact factor: 49.962

3.  Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.

Authors:  E V Valore; C H Park; A J Quayle; K R Wiles; P B McCray; T Ganz
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

4.  CD14-dependent lipopolysaccharide-induced beta-defensin-2 expression in human tracheobronchial epithelium.

Authors:  M N Becker; G Diamond; M W Verghese; S H Randell
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

5.  Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection.

Authors:  Regine Gläser; Jürgen Harder; Hans Lange; Joachim Bartels; Enno Christophers; Jens-Michael Schröder
Journal:  Nat Immunol       Date:  2004-11-28       Impact factor: 25.606

6.  Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic.

Authors:  J Harder; J Bartels; E Christophers; J M Schroder
Journal:  J Biol Chem       Date:  2000-11-20       Impact factor: 5.157

7.  Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction.

Authors:  J R García; F Jaumann; S Schulz; A Krause; J Rodríguez-Jiménez; U Forssmann; K Adermann; E Klüver; C Vogelmeier; D Becker; R Hedrich; W G Forssmann; R Bals
Journal:  Cell Tissue Res       Date:  2001-11       Impact factor: 5.249

8.  Intraarticular release and accumulation of defensins and bactericidal/permeability-increasing protein in patients with rheumatoid arthritis.

Authors:  Maria I Bokarewa; Tao Jin; Andrej Tarkowski
Journal:  J Rheumatol       Date:  2003-08       Impact factor: 4.666

Review 9.  Toll-like receptors in the pathogenesis of human disease.

Authors:  Donald N Cook; David S Pisetsky; David A Schwartz
Journal:  Nat Immunol       Date:  2004-10       Impact factor: 25.606

Review 10.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

View more
  12 in total

1.  Protective role of IL-1β against post-arthroplasty Staphylococcus aureus infection.

Authors:  Nicholas M Bernthal; Jonathan R Pribaz; Alexandra I Stavrakis; Fabrizio Billi; John S Cho; Romela Irene Ramos; Kevin P Francis; Yoichiro Iwakura; Lloyd S Miller
Journal:  J Orthop Res       Date:  2011-03-28       Impact factor: 3.494

2.  Defensins attenuate cytokine responses yet enhance antibody responses to Porphyromonas gingivalis adhesins in mice.

Authors:  Karl G Kohlgraf; Abbey Ackermann; Xiaoying Lu; Kindra Burnell; Myriam Bélanger; Joseph E Cavanaugh; Hua Xie; Ann Progulske-Fox; Kim A Brogden
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

3.  What's New in the Management of Bacterial Septic Arthritis?

Authors:  Sumeet Chander; Gerald Coakley
Journal:  Curr Infect Dis Rep       Date:  2011-10       Impact factor: 3.725

Review 4.  Novel therapeutic interventions towards improved management of septic arthritis.

Authors:  Jian Wang; Liucai Wang
Journal:  BMC Musculoskelet Disord       Date:  2021-06-09       Impact factor: 2.362

5.  Nanostructured, self-assembling peptide K5 blocks TNF-α and PGE₂ production by suppression of the AP-1/p38 pathway.

Authors:  Woo Seok Yang; Yung Chul Park; Ji Hye Kim; Hye Ri Kim; Tao Yu; Se Eun Byeon; Larry D Unsworth; Jaehwi Lee; Jae Youl Cho
Journal:  Mediators Inflamm       Date:  2012-01-24       Impact factor: 4.711

6.  Effects of Low-Level Laser Therapy, 660 nm, in Experimental Septic Arthritis.

Authors:  Bruna Formentão Araujo; Lígia Inez Silva; Anamaria Meireles; Camila Thieimi Rosa; Nereida Mello da Rosa Gioppo; Alex Sandro Jorge; Regina Inês Kunz; Lucinéia de Fátima Chasko Ribeiro; Rose Meire Costa Brancalhão; Gladson Ricardo Flor Bertolini
Journal:  ISRN Rheumatol       Date:  2013-08-12

7.  Hepatocytes express the antimicrobial peptide HBD-2 after multiple trauma: an experimental study in human and mice.

Authors:  Stefanie Fitschen-Oestern; Matthias Weuster; Sebastian Lippross; Peter Behrendt; Sabine Fuchs; Thomas Pufe; Mersedeh Tohidnezhad; Andreas Bayer; Andreas Seekamp; Deike Varoga; Tim Klüter
Journal:  BMC Musculoskelet Disord       Date:  2017-03-07       Impact factor: 2.362

8.  Induction of β-Defensin Expression by Porphyromonas gingivalis-Infected Human Gingival Graft Transplanted in nu/nu Mouse Subdermis.

Authors:  Masahiro To; Yohei Kamata; Juri Saruta; Tomoko Shimizu; Takenori Sato; Yusuke Kondo; Takashi Hayashi; Nobushiro Hamada; Keiichi Tsukinoki
Journal:  Acta Histochem Cytochem       Date:  2013-01-11       Impact factor: 1.938

9.  S100A12 and hBD2 correlate with the composition of the fecal microflora in ELBW infants and expansion of E. coli is associated with NEC.

Authors:  A C Jenke; J Postberg; B Mariel; K Hensel; D Foell; J Däbritz; S Wirth
Journal:  Biomed Res Int       Date:  2013-11-06       Impact factor: 3.411

10.  Platelet-Released Growth Factors Modulate the Secretion of Cytokines in Synoviocytes under Inflammatory Joint Disease.

Authors:  Mersedeh Tohidnezhad; Andreas Bayer; Biljana Rasuo; Jennifer Vanessa Phi Hock; Nisreen Kweider; Athanassios Fragoulis; Tolga Taha Sönmez; Holger Jahr; Thomas Pufe; Sebastian Lippross
Journal:  Mediators Inflamm       Date:  2017-11-19       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.